Valuation: Ipca Laboratories Limited

Market Cap 492B 5.25B 4.7B 4.34B 3.94B 7.45B 7.66B 51.91B 20.68B 263B 19.68B 19.27B 833B P/E 2027 *
32.3x
P/E 2028 * 27.3x
Enterprise Value 482B 5.14B 4.61B 4.25B 3.86B 7.3B 7.5B 50.86B 20.26B 258B 19.29B 18.88B 816B EV / Sales 2027 *
4.34x
EV / Sales 2028 * 3.82x
Free-Float
54.94%
Yield 2027 *
0.31%
Yield 2028 * 0.34%
1 day-1.09%
1 week-0.60%
Current month+0.55%
1 month+1.20%
3 months+14.98%
6 months+24.85%
Current year+36.61%
1 week 1,891.2
Extreme 1891.2
2,012
1 month 1,797
Extreme 1797
2,012
Current year 1,391.8
Extreme 1391.8
2,038
1 year 1,293.9
Extreme 1293.9
2,038
3 years 1,025.55
Extreme 1025.55
2,038
5 years 669.8
Extreme 669.8
2,038
10 years 200
Extreme 200
2,038
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%-0.60%+44.14%+84.48% 5.3B
-1.03%+0.40%+44.00%+132.35% 1,276B
-1.34%+0.65%+43.48%+88.38% 676B
-1.29%-1.31%+29.23%+109.88% 519B
-0.56%+1.31%+38.93%+68.00% 388B
-1.66%-2.96%+60.43%+42.39% 365B
-1.41%-1.03%+27.67%+57.03% 307B
-0.26%-1.11%+2.99%+35.32% 287B
-0.79%-3.47%+36.47%+73.19% 252B
-0.75%-2.47%+38.84%+127.10% 212B
Average -1.01%+2.15%+36.62%+81.81% 429B
Weighted average by Cap. -1.06%+2.51%+38.46%+93.53%

Financials

2027 *2028 *
Net sales 111B 1.18B 1.06B 978M 888M 1.68B 1.73B 11.71B 4.67B 59.44B 4.44B 4.35B 188B 124B 1.32B 1.18B 1.09B 990M 1.87B 1.93B 13.05B 5.2B 66.26B 4.95B 4.85B 209B
Net income 15.06B 161M 144M 133M 121M 228M 235M 1.59B 633M 8.07B 603M 590M 25.51B 18.02B 192M 172M 159M 144M 273M 281M 1.9B 758M 9.65B 721M 706M 30.52B
Net Debt -9.94B -106M -95.06M -87.6M -79.56M -151M -155M -1.05B -418M -5.32B -398M -389M -16.83B -19.57B -209M -187M -173M -157M -297M -305M -2.07B -823M -10.49B -783M -767M -33.15B
Projected Income Statement - Annual - Ipca Laboratories Limited
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-11-11 ₹1,938.40 -1.09% 248,312
26-11-09 ₹1,959.70 +1.08% 381,272
26-11-08 ₹1,938.70 -0.16% 11,793
26-11-06 ₹1,941.80 -0.40% 237,888
26-11-05 ₹1,949.60 -1.14% 609,355
Trader
Investor
Global
Quality
ESG MSCI
B
MarketScreener Ratings - Ipca Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,959.70INR
Average target price
2,068.11INR
Spread / Average Target
+5.53%
  1. Stock Market
  2. Stocks
  3. IPCALAB Stock